2020-11-27,Do Hedge Funds Love Inmune Bio Inc. (INMB)?
2020-11-17,Bexion Pharmaceuticals Announces the Addition of Dr. Raymond J. Tesi to Board of Directors
2020-11-09,"INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial of Quellor for Pulmonary Complications in COVID-19 Patients"
2020-11-05,"INmune Bio, Inc. Announces Third Quarter Results and Provides Business Update"
2020-10-29,"INmune Bio, Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on Thursday, November 5"
2020-10-26,"Do Insiders Own Lots Of Shares In INmune Bio, Inc. (NASDAQ:INMB)?"
2020-10-05,"INmune Bio, Inc. Presents Preliminary Phase I Data at 21st International Conference on Alzheimers Drug Discovery"
2020-09-23,"INmune Bio, Inc. to Host Key Opinion Leader Webinar on Treatment Resistant Depression on Tuesday, September 29"
2020-09-16,"INmune Bio, Inc. Awarded $2.9 Million NIH Small Business Innovation Research Grant to Support Phase 2 Study of XPro1595 in Patients with Treatment Resistant Depression"
2020-09-14,"INmune Bio, Inc. to Participate in Oppenheimers Fall Healthcare Life Science & Med Tech Virtual Investor Summit, on September 23, 2020."
2020-09-03,"INmune Bio, Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office Covering INKmune Therapy"
2020-09-01,"INmune Bio, Inc. Announces FDA Acceptance of IND Application to Evaluate Quellor in a Blinded Randomized Phase 2 Trial for Immune Mediated Complications in COVID-19 Patients"
2020-08-13,European Patent Granted Covering INmune Bios XPro1595
2020-08-05,"INmune Bio, Inc. Announces Second Quarter 2020 Results and Provides Business Update"
2020-08-03,"INmune Bio, Inc to Present at the BTIG Virtual Biotechnology Conference 2020"
2020-07-31,"INmune Bio, Inc. Schedules Conference Call to Report 2020 Second Quarter Financial Results"
2020-07-27,"INmune Bio, Inc. Featured on Fox News (VIDEO): STNF and Cytokine Storm"
2020-07-20,"Correction: INmune Bio, Inc. Announces Closing of $25 Million Public Offering of Common Stock Including Full Exercise of Underwriters Over-Allotment Option"
2020-07-20,"INmune Bio, Inc. Announces Closing of $25 Million Public Offering of Common Stock Including Full Exercise of Underwriters Over-Allotment Option"
2020-07-16,"INmune Bio, Inc. Prices Public Offering of Common Stock"
2020-07-15,"INmune Bio, Inc. Announces Proposed Public Offering of Common Stock"
2020-07-14,Tiny Biotech Skyrockets To A Record High On Promising Alzheimer's News
2020-07-14,"The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits"
2020-07-13,"INmune Bio, Inc. Announces Interim Phase Ib Data Demonstrating That XPro1595 Decreases Neuroinflammation in Patients with Alzheimers Disease"
2020-07-09,"INmune Bio, Inc. to Announce Interim Data from Phase Ib Clinical Study of XPro1595 in Patients with Alzheimers Disease Prior to Start of AAIC 2020"
2020-06-24,Neurotez: Can Leptin Prove Beneficial for Alzheimer's Patients?
2020-06-11,"INmune Bio, Inc. Receives Regulatory Approval from UK MHRA to Initiate Phase I Trial of INKmune in Patients with High-risk MDS"
2020-05-19,"Killers at the Crossroad  A Published Review of Innate Immune Cell Potential in Treatment of Cancers Published by Co-Founder and CSO of INmune Bio, Inc."
2020-05-14,"INmune Bio, Inc. Announces First Quarter 2020 Results and Provides Business Update"
2020-05-11,"INmune Bio Incs INB03 Inhibits Cell Migration, Tumor Growth, and Induces Innate Immune Response in Pre-clinical Models of Trastuzumab-Resistant HER2+ Breast Cancer"
2020-05-06,"INmune Bio, Inc. to Host First Quarter 2020 Earnings Conference Call"
2020-04-28,"INmune Bio, Inc. to Speak on COVID-19 Therapeutic Panel at Maxim Groups Infectious Disease Virtual Conference on May 5, 2020"
2020-04-28,Is INmune Bio (NASDAQ:INMB) In A Good Position To Invest In Growth?
2020-04-23,Frontiers in Oncology Publishes an Invited Review Highlighting Soluble TNFs Impact on Breast Cancer
2020-04-22,INMB: Evaluating DN-TNF as COVID-19 Treatment
2020-04-22,INmune Bio Announces Allowance of U.S. Patent Covering Method for Treating Cancer by In Vivo Priming of Natural Killer Cells
2020-04-20,"INmune Bio, Inc. Announces Initiation of Clinical Program Targeting Soluble TNF to Determine if the Companys TNF Inhibitor (DN-TNF) Platform May Prevent Complications of Cytokine Storm Caused by COVID-19"
2020-03-16,INMB: Multiple Milestones Ahead in 2020
2020-03-11,"INmune Bio, Inc. Reports Fourth Quarter and Full Year 2019 Results - Drug Pipeline Expands to Now Include Cancer, Alzheimers Disease and NASH"
2020-03-05,"INmune Bio, Inc. to Present at the 32nd Annual ROTH Conference on March 17"
2020-02-27,"INmune Bio, Inc. Schedules Conference Call to Report 2019 Fourth Quarter and Full Year Financial Results"
2020-02-10,"INmune Bio, Inc. Awarded $500,000 Grant for Development of Novel Treatment to Reprogram Innate Immune System in People Living with ALS"
2020-01-29,Have Insiders Been Buying INmune Bio Inc. (NASDAQ:INMB) Shares?
2020-01-02,"INmune Bio, Inc. Announces Data on its Lead Compound Which Highlights The Potential to Lower The Risk of Alzheimer's Disease in Obese Individuals"
2019-12-17,"INmune Bio Announces Final Phase I Clinical Data for its Soluble TNF Inhibitor, INB03, Demonstrates Efficacy and Safety; INB03 is Advancing to Phase II Trials"
2019-12-02,"INmune Bio, Inc. Announces First Alzheimers Disease Patient Dosed in XPro1595 Study"
2019-11-26,INmune Bio Inc. to Discuss Potential New Alzheimers Disease Treatments in CTAD Pre-Conference Webinar
2019-11-25,INMB: Potential Link Between Obesity and Neuroinflammation Shown in Mouse Model of Alzheimers
2019-11-19,"INmune Bio, Inc. Strengthens Board of Directors with Appointment of Veteran Finance Executive Marcia Allen"
2019-11-08,"INmune Bio, Inc. Reports Third Quarter 2019 Financial Results and Provides Shareholder Update"
2019-10-21,"INmune Bio, Inc. Announces Potentially Strong Link Between Obesity and Alzheimer's Disease at the Society for Neuroscience 49th Annual Meeting"
2019-10-21,Here's Why We're Not Too Worried About INmune Bio's (NASDAQ:INMB) Cash Burn Situation
2019-10-17,"INmune Bio, Inc. Announces Presentation of Data Related to its Lead Compound XPro1595 at the Society for Neurosciences Annual Meeting"
2019-10-08,INmune Bio Inc. to Present at Advances in Immuno-Oncology USA Congress and at World Immunotherapy Congress in October
2019-09-24,CEO of INmune Bio Inc. Discusses Company Accomplishments at Nasdaqs MarketSite and Announces Presentation at World Immunotherapy Congress
2019-09-23,INmune Bio to Present XPro1595 for Treating Neuroinflammation in Alzheimers Disease at 2019 Alzheimers Association International Conference (AAIC) Satellite Symposium
2019-09-20,6 Small Drug Stocks in Focus Ahead of World Alzheimer's Day
2019-09-17,INmune Bio Invited to Speak on Companys Advancements in Cancer Treatments at the Targeting Innate Immunity Congress and MarketsandMarkets Next Gen Immuno-Oncology Congress
2019-09-12,INmune Bio Inc. Announces USPTO Allowance of Key Patent Covering Its DN-TNFa Platform Technology for Treating Cancer
2019-09-05,"INmune Bio to Present at the H.C. Wainwright 21st Annual Healthcare Conference on Tuesday, September 10th at 2:10 p.m. ET"
2019-09-04,INmune Bio Inc. to Introduce NeuLiv Program for Treatment of NASHÂ at H.C. Wainwright 21st Annual Global Investment Conference
2019-08-21,Read This Before Selling INmune Bio Inc. (NASDAQ:INMB) Shares
2019-08-21,INMB: Positive Preliminary Phase 1 Data for INB03
2019-08-13,"The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results"
2019-08-12,INmune Bio Reports Second Quarter 2019 Financial Results and Provides Shareholder Update
2019-08-08,INmune Bio Appoints Biotechnology Executive Edgardo Baracchini as New Board Member
2019-08-06,Biotech Stocks to Watch Through the 2nd Half of 2019
2019-08-05,INmune Bio Reports Positive Preliminary Data from INB03 Phase I Clinical Trial in Cancer
2019-08-01,INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institutes 7th Annual Immuno-Oncology Summit
2019-07-25,INmune Bio Co-Founder and CEO Presents at 17th Annual Congress of International Drug Discovery Science & Technology 2019
2019-07-03,INmune Bio Co-Founder and CEO Presents at Maxim Groups Conference on Alzheimers Disease
2019-06-27,INmune Bio Announces Publication of Data on INKmune Primed NK cells in Peer-Reviewed Journal PLOS ONE
2019-06-11,INmune Bio Inc. Featured in Exclusive NetworkNewsWire Broadcast
2019-06-10,INMB: TNF- Inhibition Associated with Decreased Risk of Developing Alzheimers Disease
2019-06-04,INmune Bio to present Alzheimers Drug Candidate XPro1595 at The TNF Conference
2019-05-28,INmune Bio to Present at the 9th Annual LD Micro Invitational on June 5th
2019-05-22,INMB: Two Additional Clinical Trials Set to Initiate in 2019
2019-05-16,INmune Bio Announces Common Stock Purchase Agreement for up to $20.0 Million with Lincoln Park Capital
2019-05-15,INmune Bio Reports First Quarter 2019 Financial Results and Provides Shareholder Update
2019-05-07,Do Insiders Own Lots Of Shares In INmune Bio Inc. (NASDAQ:INMB)?
2019-05-07,"INmune Bio Closes Private Placement of Approximately $4.1 Million of Common Stock, Led by Insiders and Existing Shareholders"
2019-04-17,INmune Bio Presenting Poster at the Neuroimmunology Drug Development Summit
2019-04-15,INMB: Initiating Coverage of INmune Bio; Immunotherapy Utilizing the Innate Immune System
2019-04-09,"Univest Client INmune Bio, Inc. (""INMB) to Ring NASDAQ Closing Bell"
2019-04-09,INmune Bio looks to help treat Alzheimer's disease and cancer after IPO this year
2019-04-09,INmune Bio Co-Founder and CEO to Speak at Cambridge Healthtech Institutes 10th Annual Inflammation Inhibitors Conference
2019-04-08,"INmune Bio Announces Poster Presentation with New Data Regarding Neurodegenerative Disease Drug Candidate, XPro1595, at The European Conference on Neuroinflammation"
2019-04-02,"INmune Bio to Ring the NASDAQ Closing Bell on Tuesday, April 9, 2019"
2019-03-19,INmune Bio Co-Founder and CEO Presented at Cambridge Healthtech Institutes 4th Annual Immuno-Oncology Summit Europe 2019
2019-02-26,INmune Bio Co-Founders to Present at World Immunotherapy Congress during the Festival of Biologics San Diego
2019-02-11,INmune Bio Awarded a $1 Million Grant for the Development of XPro1595 for the treatment of Alzheimers Disease
2019-02-06,"WestPark Capital Announces the Completion of an $8 Million IPO For INmune Bio, Inc."
2019-02-06,INmune Bio to Present at BIO CEO & Investor Conference
2019-02-04,INmune Bio Inc. Announces Closing of Initial Public Offering and Trading on the Nasdaq Capital Market Under the Ticker Symbol INMB
